Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on: April 30,2024 0

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on:April 30,2024 0

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on: June 04,2024 6

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on:June 04,2024 6

How a novel drug pushes the HIV capsid to breaking point

by University of New South WalesLenacapavir causes the HIV capsid to rupture before it can transport its genetic material to the host cell nucleus. Credit: Public Health Image Library, CDCJust ov

Updated on: June 04,2024 3

How a novel drug pushes the HIV capsid to breaking point

by University of New South WalesLenacapavir causes the HIV capsid to rupture before it can transport its genetic material to the host cell nucleus. Credit: Public Health Image Library, CDCJust ov

Updated on:June 04,2024 3

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on: April 16,2024 14

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on:April 16,2024 14

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on: May 05,2024 18

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on:May 05,2024 18

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on: April 16,2024 13

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on:April 16,2024 13

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on: June 14,2024 3

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on:June 14,2024 3

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on: March 26,2024 11

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on:March 26,2024 11

Lolamicin: A Revolutionary Antibiotic Targeting Gram-Negative Bacteria Without Disrupting the Gut Microbiome

Updated on: June 01,2024 0

Lolamicin: A Revolutionary Antibiotic Targeting Gram-Negative Bacteria Without Disrupting the Gut Microbiome

Updated on:June 01,2024 0

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on: June 05,2024 0

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on:June 05,2024 0

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on: April 16,2024 16

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on:April 16,2024 16

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on: April 16,2024 18

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on:April 16,2024 18